{"schema_version":"secwatch.filing_event.v1","accession":"0001023024-25-000049","form_type":"8-K","ticker":"ANIP","cik":"0001023024","company_name":"ANI PHARMACEUTICALS INC","filed_at":"2025-05-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.170872+00:00","generated_at":"2026-05-20T23:28:34.779201+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"ANI Pharmaceuticals presents at conference; no new material financial disclosure","bullets":["CEO Nikhil Lalwani presenting at H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20, 2025.","Investor presentation furnished as Exhibit 99.1; no specific financial results or guidance included in the 8-K.","Presentation likely covers corporate overview and recent developments, but details not provided in filing text."],"urls":{"canonical":"https://secwatch.observer/filing/0001023024-25-000049","json":"https://secwatch.observer/filing/0001023024-25-000049.json","markdown":"https://secwatch.observer/filing/0001023024-25-000049.md","text":"https://secwatch.observer/filing/0001023024-25-000049.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1023024/000102302425000049/0001023024-25-000049-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1023024/000102302425000049/ani-20250520.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T23:28:34.779201+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}